0001438133-23-000123.txt : 20230530
0001438133-23-000123.hdr.sgml : 20230530
20230530212153
ACCESSION NUMBER: 0001438133-23-000123
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230525
FILED AS OF DATE: 20230530
DATE AS OF CHANGE: 20230530
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sheridan John F
CENTRAL INDEX KEY: 0001365369
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36189
FILM NUMBER: 23978721
MAIL ADDRESS:
STREET 1: C/O TANDEM DIABETES CARE, INC.
STREET 2: 11045 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC
CENTRAL INDEX KEY: 0001438133
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204327508
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12400 HIGH BLUFF DRIVE
CITY: San Diego
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-366-6900
MAIL ADDRESS:
STREET 1: 12400 HIGH BLUFF DRIVE
CITY: San Diego
STATE: CA
ZIP: 92130
4
1
wf-form4_168549608669152.xml
FORM 4
X0407
4
2023-05-25
0
0001438133
TANDEM DIABETES CARE INC
TNDM
0001365369
Sheridan John F
12400 HIGH BLUFF DRIVE
SAN DIEGO
CA
92130
1
1
0
0
PRESIDENT & CEO
0
Common Stock
2023-05-30
4
M
0
820
0
A
22728
D
Common Stock
2023-05-30
4
F
0
284
26.57
D
22444
D
RSU 2023 05 25
0.0
2023-05-25
4
A
0
65659
0
A
Common Stock
65659.0
65659
D
PSU 2023 05 25
0.0
2023-05-25
4
A
0
65659
0
A
Common Stock
65659.0
65659
D
Restricted Stock Unit
2023-05-30
4
M
0
820
0
D
Common Stock
820.0
3279
D
Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).
Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
RSU vest as to thiry-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
Each performance stock unit (PSU) represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the Company) common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2025 (the Measurement Date). The number of shares issued may range from 0% to 200% of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.
Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).
RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.
/s/ Rachel Malina , Attorney-in-Fact for John F. Sheridan
2023-05-30